Literature DB >> 23380718

In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.

S Deng1, G S de Hoog, H Badali, L Yang, M J Najafzadeh, B Pan, I Curfs-Breuker, J F Meis, W Liao.   

Abstract

A global collection of Cladophialophora carrionii strains (n = 81) was tested against nine antifungal drugs. MIC90s of all strains were as follows in increasing order: itraconazole and posaconazole, 0.063 μg/ml; terbinafine, 0.125 μg/ml; isavuconazole and voriconazole, 0.25 μg/ml; caspofungin, 2 μg/ml; micafungin, 4 μg/ml; amphotericin B, 8 μg/ml; and fluconazole, 64 μg/ml.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23380718      PMCID： PMC3623317          DOI： 10.1128/AAC.02114-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  The natural habitat of Cladosporium carrionii, a cause of chromoblastomycosis in man.

Authors:  M F RIDLEY
Journal:  Aust J Dermatol       Date:  1957-06

2.  Molecular diversity of Cladophialophora carrionii in patients with chromoblastomycosis in Venezuela.

Authors:  Gloria M González; O Carolina Rojas; Virgilio Bocanegra-García; J Gerardo González; Elvira Garza-González
Journal:  Med Mycol       Date:  2012-06-27       Impact factor: 4.076

3.  Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.

Authors:  Enrique Calvo; F Javier Pastor; Valentina Salas; Emilio Mayayo; Javier Capilla; Josep Guarro
Journal:  J Antimicrob Chemother       Date:  2011-12-21       Impact factor: 5.790

Review 4.  Chromoblastomycosis in India.

Authors:  C Rajendran; V Ramesh; R S Misra; S Kandhari; H B Upreti; K K Datta
Journal:  Int J Dermatol       Date:  1997-01       Impact factor: 2.736

Review 5.  Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

6.  In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp.

Authors:  Mohammad J Najafzadeh; Hamid Badali; Maria Teresa Illnait-Zaragozi; G Sybren De Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

7.  In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.

Authors:  R G Vitale; M Perez-Blanco; G S De Hoog
Journal:  Med Mycol       Date:  2009-02       Impact factor: 4.076

8.  Molecular epidemiology of Fonsecaea species.

Authors:  Mohammad Javad Najafzadeh; Jiufeng Sun; Vania A Vicente; Corne H W Klaassen; Alexandro Bonifaz; A H G Gerrits van den Ende; Steph B J Menken; G Sybren de Hoog
Journal:  Emerg Infect Dis       Date:  2011-03       Impact factor: 6.883

9.  Waterborne Exophiala species causing disease in cold-blooded animals.

Authors:  G S de Hoog; V A Vicente; M J Najafzadeh; M J Harrak; H Badali; S Seyedmousavi
Journal:  Persoonia       Date:  2011-11-16       Impact factor: 11.051
View more
  5 in total

1.  In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.

Authors:  M J Najafzadeh; M Saradeghi Keisari; V A Vicente; P Feng; S A A Shamsian; A Rezaei-Matehkolaei; G S de Hoog; I Curfs-Breuker; J F Meis
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

2.  In vitro activities of nine antifungal drugs and their combinations against Phialophora verrucosa.

Authors:  Yali Li; Zhe Wan; Ruoyu Li
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

3.  In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and Relatives.

Authors:  Gholam Reza Shokoohi; Hamid Badali; Hossein Mirhendi; Saham Ansari; Ali Rezaei-Matehkolaei; Bahram Ahmadi; Afsane Vaezi; Mohamed Mahdi Alshahni; Koichi Makimura
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

Review 4.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Novel treatment using topical malachite green for nasal phaeohyphomycosis caused by a new Cladophialophora species in a cat.

Authors:  Ian J Brooks; Stuart A Walton; Justin Shmalberg; Autumn Harris
Journal:  JFMS Open Rep       Date:  2018-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.